CYBB and Alzheimer disease: A similar finding also confirmed that Rg1 reduced neuronal damage, cognitive impairment, and Aβ deposition by decreasing NADPH-oxidase2 (NOX2) activation in APP/PS1 mice, the most commonly used AD model (Zhang et al., 2021).